RT Journal Article
SR Electronic
T1 Pleiotropic Loci for Cannabis Use Disorder Severity in Multi-Ancestry High-Risk Populations
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2022.11.25.22282743
DO 10.1101/2022.11.25.22282743
A1 Peng, Qian
A1 Wilhelmsen, Kirk C.
A1 Ehlers, Cindy L.
YR 2022
UL http://medrxiv.org/content/early/2022/11/27/2022.11.25.22282743.abstract
AB Cannabis use disorder (CUD) is common and has in part a genetic basis. The risk factors underlying its development likely involve multiple genes that are polygenetic and interact with each other and the environment to ultimately lead to the disorder. Co-morbidity and genetic correlations have been identified between CUD and other disorders and traits in select populations primarily of European descent. If two or more traits, such as CUD and another disorder, are affected by the same genetic locus, they are said to be pleiotropic. The present study aimed to identify specific pleiotropic loci for the severity level of CUD in three high-risk population cohorts: American Indians (AI), Mexican Americans (MA), and European Americans (EA). Using a previously developed computational method based on a machine learning technique, we leveraged the entire GWAS catalog and identified 114, 119, and 165 potentially pleiotropic variants for CUD severity in AI, MA, and EA respectively. Ten pleiotropic loci were shared between the cohorts although the exact variants from each cohort differed. While majority of the pleiotropic genes were distinct in each cohort, they converged on numerous enriched biological pathways. The gene ontology terms associated with the pleiotropic genes were predominately related to synaptic functions and neurodevelopment. Notable pathways included Wnt/β-catenin signaling, lipoprotein assembly, response to UV radiation, and components of the complement system. The pleiotropic genes were the most significantly differentially expressed in frontal cortex and coronary artery, up-regulated in adipose tissue, and down-regulated in testis, prostate, and ovary. They were significantly up-regulated in most brain tissues but were down-regulated in the cerebellum and hypothalamus. Our study is the first to attempt a large-scale pleiotropy detection scan for CUD severity. Our findings suggest that the different population cohorts may have distinct genetic factors for CUD, however they share pleiotropic genes from underlying pathways related to Alzheimer’s disease, neuroplasticity, immune response, and reproductive endocrine systems.Competing Interest StatementThe authors have declared no competing interest.Funding StatementThis work was supported by the National Institutes of Health (NIH): National Institute on Drug Abuse (NIDA) DP1 DA054373 to QP; R01 DA030976 to CLE. National Institute on Alcohol Abuse and Alcoholism (NIAAA) K25 AA025095 to QP; R01 AA027316 to CLE.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:IRB of The Scripps Research Institute gave ethical approval for this work. Committee for the Protection of the Rights of Human Subject of the University of California San Francisco gave ethical approval for this work. IRB of the University of North Carolina, at Chapel Hill gave ethical approval for this work.I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data from the European American cohort under study is available in dbGaP, study accession phs001458.v1.p1. The data from the American Indian cohort under study cannot be shared publicly in accordance with the wishes of the tribes. All other data produced in the present study are available upon reasonable request to the authors.